Cameron Kevin J 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jul 12, 2018
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Award
Stock Options (right to buy)
2018-06-30+30,000→ 30,000 totalExercise: $3.76From: 2019-06-30Exp: 2028-06-30→ Common Stock (30,000 underlying) - Award
Common Stock
2018-06-30+10,000→ 186,666 total
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 30, 2019, June 30, 2020 and June 30, 2021.
- [F2]Includes 19,999 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 30, 2019, June 30, 2020 and June 30, 2021.